Cell death in cultured human Saos2 osteoblasts exposed to low-density lipoprotein

Journal of Cellular Biochemistry

Volumn 90, Issue 1, 2003, Pages 42-58

  Klein, Benjamin Y ^a   Rojansky, N ^a   Ben Yehuda, A ^a   Abou Atta, I ^a   Abedat, S ^a   Friedman, G ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Alkaline phosphatase; Apolipoprotein; Apoptosis; Atherosclerosis; Bax; Bcl 2; c Src kinase; Co morbidity; Osteoporosis; Oxidized LDL

Indexed keywords

ALKALINE PHOSPHATASE; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; LOW DENSITY LIPOPROTEIN; PHOSPHOTYROSINE; PROTEIN KINASE P60;

AGE; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL COUNT; CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL STRAIN; CELL STRAIN SAOS2; CELL STRAIN U2OS; COMORBIDITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOLYSIS; DEMENTIA; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; LIPID OXIDATION; OSTEOBLAST; OSTEOPOROSIS; PRIORITY JOURNAL; RISK FACTOR; STEM CELL; WESTERN BLOTTING;

APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BCL-2-ASSOCIATED X PROTEIN; CELL DEATH; CELL LINE; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; LIPOPROTEINS, LDL; OSTEOBLASTS; OSTEOPOROSIS; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, LDL; SRC-FAMILY KINASES;

EID: 0042320972     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10603     Document Type: Article

References (52)

1. Abe J, Takahashi M, Ishida M, Lee JD, Berk BC. 1997. c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1. J Biol Chem 272:20389-20394.
2. Abu-Amer Y, Ross FP, McHugh KP, Livolsi A, Peyron JF, Teitelbaum SL. 1998. Tumor necrosis factor-alpha activation of nuclear transcription factor-kappaB in marrow macrophages is mediated by c-Src tyrosine phosphorylation of Ikappa Balpha. J Biol Chem 273:29417-29423.
3. Antonsson B, Conti F, Ciavatta A, Montessuit S, Lewis S, Martinou I, Bernasconi L, Bernard A, Mermod JJ, Mazzei G, Maundrell K, Gambale F, Sadoul R, Martinou JC. 1997. Inhibition of Bax channel-forming activity by Bcl-2. Science 277:370-372.
4. Bachner D, Schroder D, Betat N, Ahrens M, Gross G. 1999. Apolipoprotein E (ApoE), a bone morphogenetic protein (Bmp-2) upregulated gene in mesenchymal progenitors (C3H10T1/2), is highly expressed in murine embryonic development. Biofactors 9:11-17.
5. Ben-Bassat H, Rosenbaum-Mitrani S, Hartzstark Z, Levitzki R, Chaouat M, Shlomai Z, Klein BY, Kleinberger-Doron N, Gazit A, Tsvieli R, Levitzki A. 1999. Tyrphostins that suppress the growth of human papilloma virus 16-immortalized human keratinocytes. J Pharmacol Exp Ther 290:1442-1457.
6. Boyce BF, Yoneda T, Lowe C, Soriano P, Mundy GR. 1992. Requirement of pp60c-Src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 90:1622-1627.
7. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP. 2002. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513-1521.
8. Brenner C, Cadiou H, Vieira HL, Zamzami N, Marzo I, Xie Z, Leber B, Andrews D, Duclohier H, Reed JC, Kroemer G. 2000. Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene 19:329-336.
9. Cauley JA, Zmuda JM, Yaffe K, Kuller LH, Ferrell RE, Wisniewski SR, Cummings SR. 1999. Apolipoprotein E polymorphism: A new genetic marker of hip fracture risk - the study of osteoporotic fractures. J Bone Miner Res 14:1175-1181.
10. Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV. 1994. Differentiation of human bone marrow osteogenic stromal cells in vitro: Induction of the osteoblast phenotype by dexamethasone. Endocrinology 134:277-286.
11. Colles SM, Maxson JM, Carlson SG, Chisolm GM. 2001. Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols. Trends Cardiovasc Med 11:131-138.
12. Deigner HP, Claus R, Bonaterra GA, Gehrke C, Bibak N, Blaess M, Cantz M, Metz J, Kinscherf R. 2001. Ceramide induces aSMase expression: Implications for OxLDL-induced apoptosis. FASEB J 15:807-814.
13. Diascro DD, Jr., Vogel RL, Johnson TE, Witherup KM, Pitzenberger SM, Rutledge SJ, Prescott DJ, Rodan GA, Schmidt A. 1998. High fatty acid content in rabbit serum is responsible for the differentiation of osteoblasts into adipocyte-like cells. J Bone Miner Res 13:96-106.
14. Doherty MJ, Ashton BA, Walsh S, Beresford JN, Grant ME, Canfield AE. 1998. Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res 13:828-838.
15. Dong Y, Lathrop W, Weaver D, Qiu Q, Cini J, Bertolini D, Chen D. 1998. Molecular cloning and characterization of LR3, a novel LDL receptor family protein with mitogenic activity. Biochem Biophys Res Commun 251:784-790.
16. Drake TA, Schadt E, Hannani K, Kabo JM, Krass K, Colinayo V, Greaser LE III, Goldin J, Lusis AJ. 2001. Genetic loci determining bone density in mice with diet-induced atherosclerosis. Physiol Genomics 5:205-215.
17. 2+ ions. J Cell Biol 143:217-224.
18. Havel RJEH, Bragdon JH. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34:1345-1353.
19. Hixson JE, Vernier DT. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545-548.
20. Hofbauer R, Denhardt DT. 1991. Cell cycle-regulated and proliferation stimulus-responsive genes. Crit Rev Eukaryot Gene Expr 1:247-300.
21. Hofbauer LC, Schoppet M. 2002. Osteoprotegerin gene polymorphism and the risk of osteoporosis and vascular disease. J Clin Endocrinol Metab 87:4078-4079.
22. Hofbauer LC, Maisch B, Schaefer JR. 2002. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 347:943-944. Discussion.
23. Horne WC, Neff L, Chatterjee D, Lomri A, Levy JB, Baron R. 1992. Osteoclasts express high levels of pp60c-Src in association with intracellular membranes. J Cell Biol 119:1003-1013.
24. Kado DM, Browner WS, Blackwell T, Gore R, Cummings SR. 2000. Rate of bone loss is associated with mortality in older women: A prospective study. J Bone Miner Res 15:1974-1980.
25. Kamalia N, McCulloch CA, Tenebaum HC, Limeback H. 1992. Dexamethasone recruitment of self-renewing osteoprogenitor cells in chick bone marrow stromal cell cultures. Blood 79:320-326.
26. Kintscher U, Wakino S, Kim S, Fleck E, Hsueh WA, Law RE. 2001. Angiotensin II induces migration and Pyk2/paxillin phosphorylation of human monocytes. Hypertension 37:587-593.
27. Klein BY, Gal I, Hartshtark Z, Segal D. 1993a. Induction of osteoprogenitor cell differentiation in rat marrow stroma increases mitochondrial retention of rhodamine 123 in stromal cells. J Cell Biochem 53:190-197.
28. Klein BY, Gal I, Segal D. 1993b. Selection of malonate-resistant stromal cell-derived osteoprogenitor cells in vitro. J Cell Biochem 51:190-197.
29. Klein BY, Gal I, Ben-Bassat H. 1996a. Cell-mediated mineralization in culture at low temperature associated with subtle thermogenic response. J Cell Biochem 63:229-238.
30. Klein BY, Gal I, Libergal M, Ben-Bassat H. 1996b. Opposing effects on mitochondrial membrane potential by malonate and levamisole, whose effect on cell-mediated mineralization is antagonistic. J Cell Biochem 60:139-147.
31. Klein BY, Gal I, Mosheiff R, Liebergall M, Ben-Bassat H. 1997a. Cyclosporin A and its non-immunosuppressive derivative exhibit a differential effect on cell-mediated mineralization in culture. J Cell Biochem 64:209-216.
32. Klein BY, Tepper SH, Gal I, Shlomai Z, Ben-Bassat H. 1997b. Opposing effects of tyrosine kinase inhibitors on mineralization of normal and tumor bone cells. J Cell Biochem 65:420-429.
33. Klein BY, Levitzki R, Ben-Bassat H. 1998. Src protein and tyrosine-phosphorylated protein profiles in marrow stroma during osteogenic stimulation. J Cell Biochem 69:316-325.
34. Leake R. 1996. The cell cycle and regulation of cancer cell growth. Ann NY Acad Sci 784:252-262.
35. Leboy PS, Beresford JN, Devlin C, Owen ME. 1991. Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures. J Cell Physiol 146:370-378.
36. Lecka-Czernik B, Moerman EJ, Grant DF, Lehmann JM, Manolagas SC, Jilka RL. 2002. Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 143:2376-2384.
37. Lipsich LA, Lewis AJ, Brugge JS. 1983. Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses. J Virol 48:352-360.
38. Marzia M, Sims NA, Voit S, Migliaccio S, Taranta A, Bernardini S, Faraggiana T, Yoneda T, Mundy GR, Boyce BF, Baron R, Teti A. 2000. Decreased c-Src expression enhances osteoblast differentiation and bone formation. J Cell Biol 151:311-320.
39. Moon J, Bandy B, Davison AJ. 1992. Hypothesis: Etiology of atherosclerosis and osteoporosis: Are imbalances in the calciferol endocrine system implicated? J Am Coll Nutr 11:567-583.
40. Nuttall ME, Patton AJ, Olivera DL, Nadeau DP, Gowen M. 1998. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: Implications for osteopenic disorders. J Bone Miner Res 13:371-382.
41. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL. 1997. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17:680-687.
42. Parhami F, Jackson SM, Tintut Y, Le V, Balucan JP, Territo M, Demer LL. 1999. Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res 14:2067-2078.
43. Parhami F, Tintut Y, Beamer WG, Gharavi N, Goodman W, Demer LL. 2001. Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Miner Res 16:182-188.
44. Reed JC. 1997. Double identity for proteins of the Bcl-2 family. Nature 387:773-776.
45. Roodman GD. 1999. Cell biology of the osteoclast. Exp Hematol 27:1229-1241.
46. Ruvolo PP, Deng X, Ito T, Carr BK, May WS. 1999. Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A. J Biol Chem 274:20296-20300.
47. Suzaki Y, Yoshizumi M, Kagami S, Koyama AH, Taketani Y, Houchi H, Tsuchiya K, Takeda E, Tamaki T. 2002. Hydrogen peroxide stimulates c-Src-mediated big mitogen-activated protein kinase 1 (BMK1) and the MEF2C signaling pathway in PC12 cells: Potential role in cell survival following oxidative insults. J Biol Chem 277:9614-9621.
48. Tolar M, Keller JN, Chan S, Mattson MP, Marques MA, Crutcher KA. 1999. Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity. J Neurosci 19:7100-7110.
49. Van Hul E, Gram J, Bollerslev J, Van Wesenbeeck L, Mathysen D, Andersen PE, Vanhoenacker F, Van Hul W. 2002. Localization of the gene causing autosomal dominant osteoporosis type 1 to chromosome 11q12-13. J Bone Miner Res 17:1111-1117.
50. Vogt MT, San Valentin R, Forrest KY, Nevitt MC, Cauley JA. 1997. Bone mineral density and aortic calcification: The study of osteoporotic fractures. J Am Geriatr Soc 45:140-145.
51. Watanabe T, Pakala R, Katagiri T, Benedict CR. 2001. Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells. Circulation 104:16-18.
52. Yamabe Y, Shimamoto A, Goto M, Yokota J, Sugawara M, Furuichi Y. 1998. Sp1-mediated transcription of the Werner helicase gene is modulated by Rb and p53. Mol Cell Biol 18:6191-6200.